全球临床实验室服务市场:第9版
市场调查报告书
商品编码
1501227

全球临床实验室服务市场:第9版

The Worldwide Market for Clinical Laboratory Services, 9th Edition

出版日期: | 出版商: Kalorama Information | 英文 250 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

临床实验室为多种疾病提供关键分析,包括病理、免疫学、胆固醇检测、过敏检测、尿液分析和基因检测,是体外诊断市场诊断服务的基础。这些实验室对于医疗保健产业非常重要。

本报告调查了全球临床实验室服务市场,重点介绍了临床实验室行业、主要趋势和成长动力的详细概述。还总结了区域趋势和进入市场的公司概况。

目录

第1章 执行摘要

第2章 产业概论

第3章 检定服务,依专业领域

  • 测试与服务概述
  • 临床化学 - 常规和基本测试
  • 日常临床化学
  • 胆固醇值测试
  • 尿液测试
  • 血液学
  • 凝固
  • 内分泌科
  • 免疫学与微生物学
  • 过敏和食物不耐症
  • 肿瘤标记
  • 心臟标记
  • 爱滋病毒检测
  • 细胞学与组织学检测
  • 基因检测
  • 毒性测试

第4章 全球临床测试市场,依提供者群体

  • 临床测试市场:提供者概述
  • 医院和急诊机构
  • 医生和门诊诊所
  • 诊所
  • 世界各地的护理设施和辅助生活设施
  • 世界透析诊所
  • 独立测试机构

第5章 北美市场

  • 摘要
  • 美国
  • 美国市场(依测试类型)
  • 美国市场(依实验室类型)
  • 美国临床实验室产业的结构
  • 独立的临床实验室
  • 医院检查室
  • 诊所/诊所的检查室
  • 护理设施/家庭医疗护理
  • 製药实验室
  • 透析诊所
  • 加拿大

第6章 EMEA 市场

  • 摘要
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 英国
  • 瑞士

第7章 亚太市场

  • 摘要
  • 日本
  • 中国
  • 印度
  • 韩国
  • 澳洲

第8章 拉丁美洲市场

  • 摘要
  • 巴西
  • 墨西哥

第9章 主要市场参与者

  • 全球竞争概览
  • 美国竞争分析
  • 主要公司简介
  • Quest Diagnostics, Inc.
  • Laboratory Corporation of America
  • Exact Sciences Corp.
  • Sonic Healthcare Limited
  • BioReference Laboratories - An OPKO Health Subsidiary
  • Myriad Genetics, Inc.
  • SYNLAB International GmbH
  • Eurofins Scientific SE
  • H.U. Group Holdings Miraca
  • Siemens Healthineers
  • Unilabs
  • Medicover AB

第10章 市场趋势及总结

  • 世界市场概览
  • 区域概览
  • 人口成长
  • 高龄化社会
  • 疾病负担增加
  • 发展中地区的经济成长
  • 稳定已开发地区经济
  • 价格压力
  • 致力于高效率的医疗保健系统
  • 医疗服务需求普遍增加
  • 新冠肺炎(COVID-19)
  • 多重检查
  • 人工智慧和机器学习实验室的趋势
  • 分子和其他先进测试开闢了新途径
  • 数位病理学的趋势
  • 人员缺乏
简介目录
Product Code: 24-034

Discover Comprehensive Insights with Kalorama's Clinical Laboratory Services Report

Understanding the clinical laboratory market is crucial for effective business planning. "The Worldwide Market for Clinical Laboratory Services, 9th Edition" answers essential questions such as the size of the service market for clinical testing, the types of tests that are in demand, and the future trajectory of this market 2023-2028. It also identifies the companies poised to earn the most revenue and examines their strategies post-COVID-19 as the virus becomes endemic.

Why This Report is Essential for IVD Manufacturers

Kalorama Information's annual review of the clinical labs market is a must-have resource for IVD manufacturers. Clinical laboratories are fundamental to the diagnostic services within the IVD market, providing critical analysis for a myriad of disorders and diseases, including pathology, immunology, cholesterol testing, allergy testing, urinalysis, and genetic testing. These laboratories are indispensable to the healthcare industry.

Market Opportunity in Lab Services: Now in its 9th Edition

"The Worldwide Market for Clinical Laboratory Services, 9th Edition" offers a detailed overview of the clinical laboratory industry, highlighting key trends and growth drivers.

Key Features of the Report

  • Industry Overview: Gain a comprehensive understanding of the clinical laboratory industry and the trends propelling its growth.
  • Influential Statistics: Examine data on disease incidence in the U.S. and globally, demographic trends, life expectancy, and company strategies.
  • Global Focus: The report covers key regions including:
    • North America (United States, Canada)
    • Europe, Middle East, and Africa - EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland)
    • Asia Pacific (Japan, China, India, South Korea, Australia)
    • Latin America (Brazil, Mexico)

Specialty Segments Covered

  • Essential and Routine Testing: Clinical chemistry, hematology, coagulation, endocrinology
  • Immunology and Microbiology Testing
  • Cytology and Histology Testing
  • Genetic Testing
  • Toxicology Testing: Drugs of abuse
  • COVID-19

Market Segmentation by Laboratory Type

  • Independent and Reference Laboratories
  • Hospital-based Laboratories
  • Clinic-based Laboratories

Competitive Analysis

The report provides a thorough competitive analysis of leading clinical laboratory providers, offering insights into market positioning and strategic initiatives.

Data and Forecasting

  • Market Data: Pertains to the world market at the manufacturers' level.
  • Base Year: 2023
  • Historical Data: 2018 through 2022
  • Forecast Data: 2024 through 2028
  • CAGRs: Provided for the 2023-2028 period for each segment.

Challenges and Adjustments

This report is part of a regularly updated series. Each new edition reflects the latest findings, adjusting for company performance, pricing pressures, reimbursement challenges, and the ongoing impacts of COVID-19.

Exclusions

The market analysis excludes revenues from clinical trial laboratory testing, environmental testing, veterinary laboratory testing, and other similar industries.

Prepare for Future Market Trends

Stay ahead with insights into demographic trends, disease trends, new developments, company performance, mergers and acquisitions, and national expansions. This report is a critical tool for navigating the evolving clinical laboratory market landscape.

Table of Contents

Chapter One: Executive Summary

  • Industry at a Glance
    • Figure 1-1: Clinical Laboratory Service Market Overview, 2024
  • Scope and Methodology
  • Global Market Overview
    • Figure 1-2: Factors Driving Demand in Clinical Laboratory Service Market, 2024
    • Table 1-1: Global Clinical Laboratory Market Analysis, 2018-2028 ($ millions at the manufacturers' level)
    • Figure 1-3: Global Clinical Laboratory Market Analysis, 2018-2028 ($ millions)
  • Key Issues and Trends Affecting the Market
  • Leading Market Participants

Chapter Two: Industry Overview

  • Clinical Laboratory Description
    • Figure 2-1: Clinical Laboratory Order (Diagnosis, Treatment, Monitoring)
    • Figure 2-2: Global Hospital Length of Stay in Days, by Country, 2021 Average
  • Number of Laboratory Health Workers by Country
    • Figure 2-3: Global Laboratory Health Workers, by Country, 2010-2021 Average
  • The Largest Clinical Laboratory Market: The United States
  • Structure and Regulation in the U.S.
    • Certificate of Waiver
      • Table 2-1: Selected CLIA Waived Laboratory Tests
    • Certificate of Provider-Performed Microscopy Procedures (PPMP)
      • Table 2-2: Provider-Performed Microscopy Procedures
    • Certificate of Compliance and Certificate of Accreditation
      • Figure 2-4: Clinical Laboratory Certificate of Accreditation Issued, by Organization (non-exempt laboratories only), March 2024
      • Table 2-3: Clinical Laboratory Certificates Issued, by Type (non-exempt laboratories only), as of April 2023
      • Figure 2-5: Laboratory Certificate Trends, by Application Type, July 2010 - March 2024
    • States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
      • Table 2-4: CLIA Exempt States, Number of Laboratories, as of March 2024
  • Laboratory Developed Test Regulations
    • FDA
    • Directive 98/79/EC
  • Payers and Reimbursement
    • Figure 2-6: Positive Forces and Negative Forces for Payers and Reimbursement
  • Laboratory Service Payer Types
    • Table 2-5: U.S. Clinical Laboratory Revenues, by Client and Payer Type, 2023 (%)
    • Figure 2-7: Clinical Laboratory Revenues, by Client and Payer Type, 2023 Estimates (%)
  • Trends in Medicare Reimbursement
    • Figure 2-8: Medicare Reimbursement Trends, Average Reimbursement for Clinical Laboratory Services, 2009-2024
  • Health Care Reform
  • Protecting Access to Medicare Act (PAMA) of 2014
    • Table 2-6: Proposed Clinical Diagnostic Laboratory Test Rates, 2020-2027
    • Impact of CARES Act on PAMA
    • Saving Access to Laboratory Service Act (SALSA)
  • Advanced Laboratory Tests (ADLT)
    • Table 2-7: List of Approved ADLTs, 2018-March 2024
  • Bundled Insurance Payments for ESRD Patients
    • Table 2-8: Laboratory Tests Subject to ESRD Consolidated Billing (CY 2022)
  • Commercial Insurance Providers
    • Table 2-9: National Commercial Insurance Provider List, 2023
    • Figure 2-9: National Commercial Insurance Providers, by Membership and Total Revenues, 2023 ($ billions)
  • Transparency in Pricing
    • Figure 2-10: Revenue and Test Volume Trends, Quest Diagnostics, 2010-2023 ($ millions)
  • Direct-to-Consumer Testing
    • Table 2-10: Select DTC Tests and Prices by Laboratory Service Provider (Quest Direct and Labcorp On Demand) 2023 (in US $)
  • DTC in Genetic Testing
  • Expanding Cancer Test Utilization and Technologies
  • Labcorp and QIAGEN Launch new Companion Diagnostic for Metastatic Breast Cancer Therapy
  • Labcorp Launches New Test for NSCLC
  • Labcorp Offers First FDA Test for Monitoring Residual Blood Cancer Cells
  • Labcorp Launches New Test for Skin Cancer
  • Labcorp Acquires Select Assets of Invitae
  • Labcorp Launches Plasma Detect
  • Quest Diagnostics Attention to Oncology
  • Quest Collaborates with GRAIL on Oncology
  • Quest Releases Companion Diagnostic
  • Quest Offers Biocept's Liquid Biopsy Test for Lung Cancer
  • Quest Acquires Haystack Oncology
  • Quest Launches MelaNodal Predict Test
  • The Role of Information Technology
    • Table 2-11: Selected Laboratory Information Management System Providers, 2023 Vendor List
  • Industry Drivers
  • Global Demographics
    • Table 2-12: The Global Population, 1980-2050
    • Figure 2-11: The Global Population, 1980-2050 (in millions)
    • Regional Population Overview
      • Table 2-13: World Population, by Major Geographic Region, 2010-2050 (in millions)
      • Figure 2-12: World Population, by Major Geographic Region, 2010-2050 (in millions)
    • Aging Populations
      • Table 2-14: Global Population Trends Age 65+, 2000-2050 (in millions)
      • Figure 2-13: Global Population Trends Age 65+, 2000-2050 (in millions)
  • Chronic Diseases and Conditions
    • Figure 2-14: Global Prevalence of Disease, 2000, 2015, and Projected 2030 (in millions)
    • Figure 2-15: Global Causes of Death, 2000, 2010, and 2020 (in millions)
    • Figure 2-16: Change in Mortality by Disease Type, Over 2000-2020 Period (%)
  • Economic Performance
    • Health Expenditures
      • Figure 2-17: Global Health Spending as a Percentage of GDP, by Country, 2022 estimates (%)

Chapter Three: Testing Services by Specialty

  • Test and Services Overview
    • Figure 3-1: Global Clinical Laboratory Market Analysis: Service Revenue Trend, 2018-2028 ($ millions)
    • Table 3-1: Global Clinical Laboratory Market Analysis, by Test Segment (Clinical Chemistry: Routine & Essential; Immunology & Microbiology; Cytology & Histology; Genetic; Toxicology; COVID-19), 2018-2028 ($ millions at the manufacturers' level)
    • Figure 3-2: Global Clinical Laboratory Market Analysis, Segment Growth Forecast, by Test Segment (Clinical Chemistry: Routine & Essential; Immunology & Microbiology; Cytology & Histology; Genetic; Toxicology; COVID-19), CAGR 2023-2028 (%)
    • Figure 3-3: Global Clinical Laboratory Market Analysis, by Testing Service (Clinical Chemistry: Routine & Essential; Immunology & Microbiology; Cytology & Histology; Genetic; Toxicology; COVID-19), Distribution of Revenues, 2023 (%)
  • Clinical Chemistry - Routine and Essential Testing
    • Figure 3-4: Global Clinical Laboratory Market Analysis: Clinical Chemistry: Routine & Essential Testing Service Market Trend, 2018-2028 ($ millions)
    • Table 3-2: Market Overview - Routine and Essential Testing, 2023 ($ millions)
  • Routine Clinical Chemistry
  • Cholesterol Level Testing
    • Table 3-3: High Cholesterol Risk Categories
  • Urinalysis
    • Table 3-4: Normal Reference Levels in a Medical Urinalysis
  • Hematology
    • Blood Cell Count
      • Table 3-5: Laboratory Reference Parameters for CBC
  • Coagulation
  • Endocrinology
    • Thyroid Function Tests
    • Pregnancy Testing
      • Table 3-6: HCG Levels in Pregnant Women by Days Past Ovulation
  • Immunology and Microbiology
    • Figure 3-5: Global Clinical Laboratory Market Analysis: Immunology & Microbiology Testing Service Market Trend, 2018-2028 ($ millions)
    • Table 3-7: Market Overview - Immunology & Microbiology Testing, 2023 ($ millions)
  • Allergy and Food Intolerance
  • Tumor Markers
  • Cardiac Markers
  • HIV Testing
  • Cytology and Histology Testing
    • Figure 3-6: Global Clinical Laboratory Market Analysis: Cytology & Histology Testing Service Market Trend, 2018-2028 ($ millions)
    • Table 3-8: Market Overview - Cytology & Histology Testing, 2023 ($ millions)
    • Pap Test
      • Figure 3-7: Percent of Females Aged 20-69 Screened for Cervical Cancer (all screening methods), by Select Country 2019 Estimates
  • Genetic Testing
    • Figure 3-8: Global Clinical Laboratory Market Analysis: Genetic Testing Service Market Trend, 2018-2028 ($ millions)
    • Table 3-9: Market Overview - Genetic Testing, 2023 ($ millions)
  • Toxicology Testing
    • Figure 3-9: Global Clinical Laboratory Market Analysis: Toxicology Testing Service Market Trend, 2018-2028 ($ millions)
    • Table 3-10: Substance Detection Periods by Selected Test Method

Chapter Four: Global Clinical Laboratory Market by Provider Group

  • Clinical Laboratory Market: Provider Overview
    • Table 4-1: Global Clinical Laboratory Market Analysis, by Provider Segment (Hospitals, Physician Offices/Outpatient Clinics, Independent), 2023-2028 ($ millions at the manufacturers' level)
    • Figure 4-1: Global Clinical Laboratory Market Analysis, Provider Segment Growth Forecast, CAGR 2023-2028 (%)
    • Figure 4-2: Global Clinical Laboratory Market Analysis, by Provider Group, Distribution of Revenues, 2023 (%)
  • Hospitals and Acute Care Providers
    • Figure 4-3: COVID-19 Impact on Hospital-based Laboratory Testing Markets, 2021-2023 ($ millions)
    • Table 4-2: Global Clinical Laboratory Market Analysis: Hospital and Acute Care Laboratory Testing Market, 2023 and 2028 (U.S./International Estimates)
    • Figure 4-4: Hospital Beds per 1,000 Population, by Country, 2021/2022
  • Physicians and Outpatient Care Providers
    • Figure 4-5: COVID-19 Impact on Physician-based Laboratory Testing Markets, 2021-2023 ($ millions)
    • Table 4-3: Global Clinical Laboratory Market Analysis: Physician and Outpatient Care Laboratory Testing Market, 2023 and 2028 (U.S./International Estimates)
  • Physician Offices
    • Figure 4-6: Medical Doctors per 1,000 Population, by Country, 2021/2022
  • Global Nursing Establishments and Assisted Living Facilities
  • Global Dialysis Clinics
  • Independent Laboratory Providers
    • Figure 4-7: COVID-19 Impact on Independent Laboratory Testing Markets, 2021-2023 ($ millions)
    • Table 4-4: Revenues for Selected U.S.-based Reference Labs 2018-2023 ($ millions, estimated)
    • Table 4-5: Estimated Clinical Test Volume by Select Independent Laboratory, 2023 (millions of units)
    • Table 4-6: Global Clinical Laboratory Market Analysis: Independent Laboratory Testing Market, 2023 and 2028 (U.S./International Estimates)

Chapter Five: North America Market

  • Overview
    • Table 5-1: North America Market Value, by Country, 2023 ($ millions at the manufacturers' level)
  • United States
    • Table 5-2: The United States Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)
    • Figure 5-1: The United States Clinical Laboratory Service Market, Performance 2018-2028 ($ millions)
  • U.S. Market by Test Type
    • Table 5-3: The United States Clinical Laboratory Service Market, by Testing Services, Estimates and Forecast 2023 and 2028 ($ millions)
    • Figure 5-2: U.S. Clinical Laboratory Market Analysis: Testing Service Revenues, by Type, 2023 (%)
    • Figure 5-3: U.S. Clinical Laboratory Market Analysis: Testing Service Revenues Over Time, by Type, 2018-2028 ($ millions)
  • U.S. Market by Laboratory Provider Type
    • Table 5-4: The United States Clinical Laboratory Service Market, by Laboratory Type, Estimates and Forecast 2023 and 2028 ($ millions)
    • Figure 5-4: U.S. Clinical Laboratory Market Share, by Laboratory Type, 2023 (%)
    • Figure 5-5: U.S. Clinical Laboratory Market Analysis: Testing Service Revenues Over Time, by Laboratory Type, 2018-2028 ($ millions)
  • U.S. Clinical Laboratory Industry Structure
    • Figure 5-6: Growth in Clinical Laboratories, 2000-2023
    • CLIA Laboratory Registration, Laboratories by Type
      • Figure 5-7: U.S. CLIA Clinical Laboratory Registration, by Primary Laboratory Type, April 2024
      • Table 5-5: CLIA Registered Laboratories, by Type of Facility (Exempt/Non-Exempt Combined), April 2024
      • Figure 5-8: Growth Trends in CLIA Registered Laboratories, by Type of Facility (Exempt/Non-Exempt Combined) June 2020 and April 2024
      • Figure 5-9: Change in CLIA Registered Laboratories, by Type of Facility, Highest and Lowest Growth Segments, % Change, Compounded Annually 2020-2024
  • Independent Clinical Laboratories
    • Figure 5-10: Leading U.S. Independent Laboratory Groups, Distribution of Centers, December 2023 (%)
    • Growth in Independent Clinical Laboratories
      • Figure 5-11: Growth in U.S. Independent Laboratory Facilities, June 2011 through April 2024
  • Hospital-based Laboratories
    • S. Hospital Data
      • Table 5-6: U.S. Hospital Types
      • Table 5-7: AHA Statistics - U.S. Registered Hospitals, by Type, 2010-2022
      • Table 5-8: AHA Statistics for U.S. Hospitals, 2014-2022
    • S. Hospital Stay Stats
      • Figure 5-12: U.S. Hospital Length of Stay, Average by Broad Age Group, 2021
    • Growth in Hospital Clinical Laboratories
      • Figure 5-13: Growth in U.S. Hospital Laboratory Locations, June 2011 through April 2024
  • Physician-office and Clinic Laboratories
    • Number of U.S. Physicians
    • Growth in Clinical Laboratories in the Physician Office
      • Figure 5-14: Growth in U.S. Physician Office Laboratory Locations, June 2011 through April 2024
  • Nursing Facility and Home Health
    • S. Nursing Home Establishments
    • S. Home Health Facilities
    • Growth in Clinical Laboratories in the Nursing Facility and Home Health Segment
      • Figure 5-15: Growth in U.S. Nursing Facility/Home Health Laboratory Locations, June 2011 through April 2024
  • Pharmacy-based Laboratories
    • Growth in Pharmacy-Based Clinical Laboratories
      • Figure 5-16: Growth in U.S. Pharmacy-Based Laboratories, mid-2011 through April 2024
  • Dialysis Clinics
    • Growth in U.S. Dialysis Clinics and Affiliated Laboratories
      • Figure 5-17: Growth in U.S. Dialysis Clinic-based Laboratories, mid-2011 through April 2024
  • Canada
    • Table 5-9: Canada Clinical Laboratory Service Market, Estimates and Forecast 2023-2028 ($ millions)
    • Figure 5-18: Canada Clinical Laboratory Service Market, Performance 2018-2028 ($ millions)

Chapter Six: EMEA Market

  • Overview
    • Table 6-1: EMEA Market Value, by Country, 2023 ($ millions at the manufacturers' level)
    • Figure 6-1: EMEA Clinical Laboratory Service Market, Growth Projections, by Country, CAGR 2023-2028
  • Germany
    • Table 6-2: Germany Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)
    • Figure 6-2: Leading Laboratory Service Suppliers, by Estimated Distribution of Revenues, Germany, 2023 (%)
  • France
    • Table 6-3: France Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)
  • Italy
    • Table 6-4: Italy Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)
  • Spain
    • Table 6-5: Spain Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)
  • United Kingdom
    • Table 6-6: United Kingdom Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)
  • Switzerland
    • Table 6-7: Switzerland Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)

Chapter Seven: Asia Pacific Market

  • Overview
    • Table 7-1: Asia Pacific Clinical Laboratory Service Market Value, by Country, 2023 ($ millions at the manufacturers' level)
    • Figure 7-1: Asia Pacific Clinical Laboratory Service Market, Growth Projections, by Country, CAGR 2023-2028 (%)
  • Japan
    • Table 7-2: Japan Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)
  • Japan Clinical Laboratory Industry Structure
    • Figure 7-2: Japan Clinical Laboratory Industry, by Type, 2023 (%)
    • Figure 7-3: Japan Clinical Laboratory Industry, by Test Classification, 2022-2023 (%)
    • Figure 7-4: Japan Clinical Laboratory Industry, Number of Laboratories, by Prefecture, 2023 (%)
  • China
    • Table 7-3: China Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)
  • China Clinical Laboratory Industry Structure
    • Figure 7-5: China Clinical Laboratory Industry, by Type, 2023 (%)
  • India
    • Table 7-4: India Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)
  • South Korea
    • Table 7-5: South Korea Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)
  • Australia
    • Table 7-6: Australia Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)

Chapter Eight: Latin America Market

  • Overview
    • Table 8-1: Latin America Market Value, by Country, 2023 ($ millions at the manufacturers' level)
    • Figure 8-1: Latin America Clinical Laboratory Service Market, Growth Projections, by Country, CAGR 2023-2028
  • Brazil
    • Table 8-2: Brazil Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)
  • Mexico
    • Table 8-3: Mexico Clinical Laboratory Service Market, Estimates and Forecast 2023 and 2028 ($ millions)

Chapter Nine: Leading Market Participants

  • Global Competitor Summary
    • Figure 9-1: Market Participants, Global Service Revenues, Estimated 2022 and 2023 ($ millions)
  • U.S. Competitive Analysis
    • Table 9-1: Top Ten Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2023 ($ millions)
    • Figure 9-2: Top 10 Estimated U.S. Laboratory Services, Market Share of Leading Clinical Laboratory Providers, 2023 (%)
  • Select Company Profiles
  • Quest Diagnostics, Inc.
  • Company Overview
    • Table 9-2: Quest Diagnostics Corporate Details
  • Performance Review
    • Figure 9-3: Quest Diagnostics Revenue Summary, 2010-2023 ($ millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
    • COVID-19 Events and Impact
  • Laboratory Corporation of America
  • Company Overview
    • Table 9-3: Laboratory Corporation of America Corporate Details
  • Performance Review
    • Figure 9-4: Laboratory Corporation of America Revenue Summary, 2010-2023 ($ millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
    • COVID-19 Events and Impact
  • Exact Sciences Corp.
  • Company Overview
    • Table 9-4: Exact Sciences Corporate Details
  • Performance Review
    • Figure 9-5: Exact Sciences Revenue Summary, 2010-2023 ($ millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
    • COVID-19 Events and Impact
  • Sonic Healthcare Limited
  • Company Overview
    • Table 9-5: Sonic Healthcare Corporate Details
  • Performance Review
    • Figure 9-6: Sonic Healthcare Revenue Summary, 2010-2023 ($ millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • BioReference Laboratories - An OPKO Health Subsidiary
  • Company Overview
    • Table 9-6: BioReference Laboratories Corporate Details
  • Key Acquisitions, Alliances, and Partnerships
  • Performance Review
    • Figure 9-7: BioReference Laboratories Revenue Summary, 2010-2023 ($ millions)
  • Products and Services
  • Myriad Genetics, Inc.
  • Company Overview
    • Table 9-7: Myriad Genetics Corporate Details
  • Key Acquisitions, Alliances, and Partnerships
  • Performance Review
    • Figure 9-8: Myriad Genetics Revenue Summary, 2010-2023 ($ millions)
  • Products and Services
  • SYNLAB International GmbH (SYNLAB Bondco PLC)
  • Company Overview
    • Table 9-8: SYNLAB Corporate Details
  • Performance Review
    • Figure 9-9: SYNLAB Revenue Summary, 2015-2023 ($ millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
    • COVID-19 Events and Impact
  • Eurofins Scientific SE
  • Company Overview
    • Table 9-11: Eurofins Scientific Corporate Details
  • Performance Review
    • Figure 9-10: Eurofins Scientific Revenue Summary, 2010-2023 ($ millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
    • COVID-19 Events and Impact
  • H.U. Group Holdings Miraca
  • Company Overview
    • Table 9-10: H.U. Group Holdings, Inc. Corporate Details
  • Performance Review
    • Figure 9-11: H.U. Holdings Revenue Summary, 2010-2023 ($ millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Siemens Healthineers
  • Company Overview
    • Table 9-11: Siemens Healthineers Corporate Details
  • Performance Review
    • Figure 9-12: Siemens Healthineers' Revenue Summary, 2010-2023 ($ millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Unilabs
  • Company Overview
    • Table 9-12: Unilabs Corporate Details
  • Performance Review
  • Products and Services
    • COVID-19 Events and Impact
  • Medicover AB
  • Company Overview
    • Table 9-13: Medicover Corporate Details
  • Key Acquisitions, Alliances, and Partnerships
  • Performance Review
    • Figure 9-13: Medicover Revenue Summary, 2010-2023 ($ millions)
  • Products and Services

Chapter Ten: Market Trends and Summary

  • Global Market Overview
    • Table 10-1: Global Clinical Laboratory Market Analysis, 2018-2028 ($ millions at the manufacturers' level)
    • Figure 10-1: Global Clinical Laboratory Market Analysis, 2018-2028 ($ millions)
  • Regional Overview
    • Table 10-2: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2023 ($ millions)
    • Figure 10-2: Global Clinical Laboratory Market Analysis, Revenues by Region, 2023 (%)
    • Figure 10-3: Global Clinical Laboratory Market Analysis, Regional Growth Forecast, CAGR 2023-2028 (%)
    • Figure 10-4: Estimated COVID-19 Market Performance, by Region, 2023 ($ millions)
  • Population growth
  • Aging populations
  • Increasing disease burden
  • Economic growth in developing regions
  • Stabilizing economies in developed regions
  • Pricing pressures
  • Focusing on Efficient health systems
  • Overall growth in demand for health care services
  • COVID-19
  • Multiplex Testing
  • AI and Machine Learning Laboratory Trends
  • Molecular Testing and Other Advanced Testing Will Open New Avenues
  • Digital Pathology Trends
  • Staffing Shortages